AAAAAA

   
Results: 1-8 |
Results: 8
Sensitivity of soft tissue sarcoma cell lines to chemotherapeutic agents: Identification of ecteinascidin-743 as a potent cytotoxic agent
Authors: Li, WW Takahashi, N Jhanwar, S Cordon-Cardo, C Elisseyeff, Y Jimeno, J Faircloth, G Bertino, JR
Citation: Ww. Li et al., Sensitivity of soft tissue sarcoma cell lines to chemotherapeutic agents: Identification of ecteinascidin-743 as a potent cytotoxic agent, CLIN CANC R, 7(9), 2001, pp. 2908-2911
Phase I and pharmacokinetic study of esteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies
Authors: Ryan, DP Supko, JG Eder, JP Seiden, MV Demetri, G Lynch, TJ Fischman, AJ Davis, J Jimeno, J Clark, JW
Citation: Dp. Ryan et al., Phase I and pharmacokinetic study of esteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies, CLIN CANC R, 7(2), 2001, pp. 231-242
In vitro hematotoxicity of Aplidine on human bone marrow and cord blood progenitor cells
Authors: Gomez, SG Faircloth, G Lopez-Lazaro, L Jimeno, J Bueren, JA Albella, B
Citation: Sg. Gomez et al., In vitro hematotoxicity of Aplidine on human bone marrow and cord blood progenitor cells, TOX VITRO, 15(4-5), 2001, pp. 347-350
Ecteinascidin-743: A marine-derived compound in advanced, pretreated sarcoma patients - Preliminary evidence of activity
Authors: Delaloge, S Yovine, A Taamma, A Riofrio, M Brain, E Raymond, E Cottu, P Goldwasser, F Jimeno, J Misset, JL Marty, M Cvitkovic, E
Citation: S. Delaloge et al., Ecteinascidin-743: A marine-derived compound in advanced, pretreated sarcoma patients - Preliminary evidence of activity, J CL ONCOL, 19(5), 2001, pp. 1248-1255
Phase II trial of didemnin B in previously treated non-Hodgkin's lymphoma - An Eastern Cooperative Oncology Group (ECOG) study
Authors: Kucuk, O Young, ML Habermann, TM Wolf, BC Jimeno, J Cassileth, PA
Citation: O. Kucuk et al., Phase II trial of didemnin B in previously treated non-Hodgkin's lymphoma - An Eastern Cooperative Oncology Group (ECOG) study, AM J CL ONC, 23(3), 2000, pp. 273-277
Isolation and characterization of an IGROV-1 human ovarian cancer cell line made resistant to Ecteinascidin-743 (ET-743)
Authors: Erba, E Bergamaschi, D Bassano, L Ronzoni, S Di Liberti, G Muradore, I Vignati, S Faircloth, G Jimeno, J D'Incalci, M
Citation: E. Erba et al., Isolation and characterization of an IGROV-1 human ovarian cancer cell line made resistant to Ecteinascidin-743 (ET-743), BR J CANC, 82(10), 2000, pp. 1732-1739
Mode of action of thiocoraline, a natural marine compound with anti-tumouractivity
Authors: Erba, E Bergamaschi, D Ronzoni, S Faretta, M Taverna, S Bonfanti, M Catapano, CV Faircloth, G Jimeno, J D'Incalci, M
Citation: E. Erba et al., Mode of action of thiocoraline, a natural marine compound with anti-tumouractivity, BR J CANC, 80(7), 1999, pp. 971-980
Cell cycle perturbations and apoptosis induced by isohomohalichondrin B (IHB), a natural marine compound
Authors: Bergamaschi, D Ronzoni, S Taverna, S Faretta, M De Feudis, P Faircloth, G Jimeno, J Erba, E D'Incalci, M
Citation: D. Bergamaschi et al., Cell cycle perturbations and apoptosis induced by isohomohalichondrin B (IHB), a natural marine compound, BR J CANC, 79(2), 1999, pp. 267-277
Risultati: 1-8 |